Post by AESARA

A lot of real-world evidence dies at “published.” The study gets done. The abstract gets accepted. The poster goes up. And the team moves on — because in most HEOR functions, that’s where the workflow ends. But publication was never the point. The point is the decision it informs — the payer, the HCP, the access conversation. And getting evidence there in a form people can act on is a different discipline than generating it. Clinical evidence has a whole engine for this: scientific communications, agencies, field enablement. HEOR rarely does. The same teams that produce rigorous work are asked to translate, package, and disseminate it themselves — on top of the research. The shift that changes outcomes is simple to say and hard to do: plan dissemination at the same time you plan the study. Know the audience, the pathway, and what it takes to clear internal review — before the data lands, not after. That’s the work we do alongside HEOR teams: turning a book of evidence into evidence that moves. #HEOR #RWE #MarketAccess #ValueAndAccess #MedicalAffairs